Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer

Title:	Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer
Authors:	Garrido, Charo^{Aff1, IDs0042802303671x_cor1}; Manoogian, Melissa^{Aff2, IDs0042802303671x_cor2}; Ghambire, Dhiraj^Aff1; Lucas, Shawn^Aff2; Karnoub, Maha^Aff1; Olson, Matthew T.^Aff2; Hicks, David G.^Aff3; Tozbikian, Gary^Aff4; Prat, Aleix^Aff5; Ueno, Naoto T.^Aff6; Modi, Shanu^Aff7; Feng, Wenqin^Aff1; Pugh, Judith^Aff2; Hsu, Ching^Aff1; Tsurutani, Junji^Aff8; Cameron, David^Aff9; Harbeck, Nadia^Aff10; Fang, Qijun^Aff2; Khambata-Ford, Shirin^Aff1; Liu, Xuemin^Aff2; Inge, Landon J.^Aff2; Vitazka, Patrik^{Aff1, Aff11}
Source:	Virchows Archiv: European Journal of Pathology. 484(6):1005-1014
Database:	Springer Nature Journals